Skip Navigation

United States Department of Health & Human Services
line

Print Print    Download Reader PDF

This is an archive page. The links are no longer being updated.

FOR IMMEDIATE RELEASE
Wednesday, May 1, 2002
Contact: FDA Press Office
(301) 827-6250

FDA PROPOSES FIRST REQUIREMENT FOR ELECTRONIC SUBMISSIONS


The Food and Drug Administration today issued a proposed rule that would require certain labeling submitted for review with new drug applications (NDAs), certain biological license applications (BLAs), abbreviated new drug applications (ANDAs), supplements, and annual reports to be submitted to the agency in electronic format. The rule, when finalized, would be the first FDA regulation to require submission of information by electronic means. It would also be FDA's first regulation issued under the President's "e-government" initiative.

"Submitting the content of labeling in electronic format would simplify the drug labeling review process and speed up the approval of labeling changes," said HHS Secretary Tommy G. Thompson. "This is part of the larger effort President Bush has ordered to use electronic data technologies to improve the federal government's efficiency and our service to Americans."

FDA has worked since 1997 to enable submission of information via electronic means, but has not previously required electronic submission. In today's proposal, the agency says the electronic format would enable more rapid and accurate review of the content of labeling.

Each year, FDA receives more than 1,000 proposed labeling changes for NDAs and BLAs and more than 2,600 proposed original and supplemental labeling changes for ANDAs. As part of the review process, FDA conducts word-for-word comparisons to ensure accuracy and currency of the information.

"Electronic submissions will allow computer matching that will greatly enhance the accuracy and speed of this part of the review," said Dr. Lester M. Crawford, FDA deputy commissioner.

Other efforts currently underway at HHS to expand efficiency through the use of electronic data technologies include:

The proposed rule will be published in the May 3 Federal Register with a 90-day comment period. Written comments may be submitted to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. Electronic comments may be sent to www.fda.gov/dockets/ecomments.

###


Note: All HHS press releases, fact sheets and other press materials are available at www.hhs.gov/news.

HHS Home | Topics | A-Z | What's New | For Kids | FAQs (answers.hhs.gov)| Site Info
Disclaimers | Privacy Notice | FOIA | Accessibility | Contact Us
Last revised: May 1, 2002